SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Jul-22 9:27 PM View: | Entasis Therapeutics Holdin... (ETTX) | 11-Jul-22 | Purchase | 7,598,810 | $2.20 | $16,717,400.00 | 12% 62.02M to 69.61M | |
13-Jul-22 9:27 PM View: | Entasis Therapeutics Holdin... (ETTX) | 08-Jul-22 | Private Purchase | 11,671,700 | $2.20 | $25,677,700.00 | 23% 50.34M to 62.02M | |
01-Apr-22 4:52 PM View: | Targeted Genetics Corp. (ARMP) | 31-Mar-22 | Market Purchase | 5,385,210 | $5.00 | $26,926,000.00 | 27% 19.69M to 25.08M | 3% |
11-Feb-22 6:56 PM View: | Targeted Genetics Corp. (ARMP) | 09-Feb-22 | Market Purchase | 3,614,790 | $5.00 | $18,074,000.00 | 22% 16.08M to 19.69M | 3% |
01-Nov-21 2:20 PM View: | Targeted Genetics Corp. (ARMP) | 29-Oct-21 | Market Purchase | 1,212,120 | $3.30 | $4,000,000.00 | 8% 14.86M to 16.08M | |
11-Jun-21 5:39 PM View: | Entasis Therapeutics Holdin... (ETTX) | 11-Jun-21 | Private Purchase | 6,268,980 | $2.00 | $12,538,000.00 | 28% 22.4M to 28.67M | |
20-May-21 2:39 PM View: | Entasis Therapeutics Holdin... (ETTX) | 03-May-21 | Private Purchase | 3,731,020 | $2.00 | $7,462,050.00 | 20% 18.67M to 22.4M | |
17-Mar-21 5:16 PM View: | Targeted Genetics Corp. (ARMP) | 17-Mar-21 | Private Purchase | 4,285,940 | $3.25 | $13,929,300.00 | 41% 10.58M to 14.86M | |
28-Jan-21 1:43 PM View: | Targeted Genetics Corp. (ARMP) | 26-Jan-21 | Private Purchase | 1,867,910 | $3.25 | $6,070,710.00 | 21% 8.71M to 10.58M | |
01-Sep-20 5:31 PM View: | Entasis Therapeutics Holdin... (ETTX) | 01-Sep-20 | Private Purchase | 4,672,900 | $2.67 | $12,500,000.00 | 33% 14.0M to 18.67M | |
12-Jun-20 5:34 PM View: | Entasis Therapeutics Holdin... (ETTX) | 11-Jun-20 | Private Purchase | 12,677,500 | $2.50 | $31,693,700.00 | 959% 1.32M to 14.0M | |
31-Mar-20 4:54 PM View: | Targeted Genetics Corp. (ARMP) | 27-Mar-20 | Private Purchase | 7,717,660 | $2.87 | $22,149,700.00 | 777% 993.14K to 8.71M | (100%) |
19-May-14 7:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-May-14 | Disposition (other) | 33,100,000 | -- | -- | (100%) 33.1M to 0 |